Project Grant HT9425261E062
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Urbana, IL 61801, USA
Similar Awards
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded a $1,465,443 Project Grant to the University of Illinois, with performance from September 1, 2025, through August 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). The grant supports research on "The Promise of Epigenetic Therapy for Refractory Testicular Germ Cell Tumors," advancing innovative biomedical solutions for cancer treatment. The research will be conducted at the...
- Federal Project Grant Award Summary The University of Illinois received a $400,814 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective October 1, 2025 through September 30, 2028. The award funds development of a Portable Panretinal Imager for Automated Detection of Retinal Detachment in Austere Environments. This research initiative aligns with DHA's mission to support hypothesis-driven biomedical innovation...
- The University of Illinois was awarded a $1,235,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award, with a performance period from August 15, 2025 to August 14, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader...
- Federal Project Grant Award Summary The University of Illinois has been awarded $555,100 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year project commencing August 1, 2025 and concluding July 31, 2028. The project, titled "Testicular Germ Cell Tumors as a Sentinel Cancer of PFAS Exposure," supports advanced biomedical research investigating the relationship between perfluoroalkyl and polyfluoroalkyl substances...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- Federal Grant Award Summary The University of Chicago received a $869,193 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2028. The award funds research to identify the pathogenesis of monosomy 7 in bone marrow failure (BMF), a basic biomedical research initiative aligned with the program's objective to transform healthcare for service members and the American public through...
- Federal Grant Award Summary The University of Illinois received a $779,173 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2028. The award supports the development of a portable panretinal imager designed to enable automated detection of retinal detachment in austere environments. This research and development initiative addresses a critical military health priority...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a $699,751 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2026, with a completion date of April 30, 2029. The award funds research to unveil mechanisms and develop innovative therapeutic interventions targeting ESR1-CCDC170 fusions in clinically aggressive, endocrine-resistant, and metastatic breast cancers. This research initiative represents the DHA's...
- The University of Illinois was awarded a $719,550 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. The grant, with an April 1, 2024 award date and March 31, 2027 completion date, will support research on the TRKA-MLK3 axis as an actionable target in triple-negative breast cancer. The project aims to advance scientific understanding and develop new treatments related to this specific type of breast cancer, which is a key...
- This federal Project Grant award of $1,612,104.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Chicago to develop senescent tumor cell-loaded dendritic cell vaccines for breast cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges. The 3-year...